非布司他片与别嘌呤醇片应用于治疗高尿酸血症伴痛风的临床对比(2)
参考文献
[1]陶小军，金星，陶沙，等.不同剂量非布司他对痛风伴高尿酸血症的效果及对内皮素-1水平的影响[J].中国全科医学，2014，17(2)：170-172.
[2]陈翔，蔡吓明，陈国勇.非布司他治疗痛风伴高尿酸血症疗效观察[J].中外医学研究，2015，13(34)：34-36.
[3] Bhat V，Sankaran H，Narula G，et al.Banavali.Single fixed dose rasburicase for treatment of hyperuricemia in children with hematolymphoid malignancy and laboratory tumor lysis syndrome (tls)：a retrospective analysis.[J].Pediatric Hematology Oncology Journal，2018，3(3)：55-56.
[4] Jing-wei Wu，Ling Yin，Yu-qiang Liu，et al.Synthesis，biological evaluation and 3D-QSAR studies of 1，2，4-triazole-5-substituted carboxylic acid bioisosteres as uric acid transporter 1 (URAT1) inhibitors for the treatment of hyperuricemia associated with gout[J].Bioorganic & Medicinal Chemistry Letters，2018(4)：545.
[5]秦萍，劉蒙蒙，孟志云，等.非布司他治疗慢性肾衰竭非透析患者高尿酸血症的疗效观察[J].现代药物与临床，2016，31(2)：219-223.
[6] Om Prakash Sharma，Mahek V Shah，Dhaivat C Parikh，et al.
Formulation optimization of gastroretentive drug delivery system for allopurinol using experimental design[J].Expert Opinion on Drug Delivery，2015，12(4)：513-524.
[7] Helmy Sally A，El-Bedaiwy Heba M.Pharmacokinetics and comparative bioavailability of allopurinol formulations in healthy subjects[J].Clinical Pharmacology in Drug Development，2014，3(5)：353-357.
[8]陆玉鹏，李义凯，李益军，等.痛风定胶囊联合非布司他对高尿酸血症患者炎性因子的影响及其疗效[J].中国生化药物杂志，2016，36(1)：59-61.
[9] Keen H I，Davis W A，Drinkwater J J，et al.Ultrasonographic assessment of joint pathology in type 2 diabetes and hyperuricemia：The Fremantle Diabetes Study Phase Ⅱ[J].Journal of Diabetes and Its Complications，2018，32(4)：400-405.
[10]万志红.非布司他治疗痛风及高尿酸血症的疗效及不良反应观察[J].中国实用医药，2016，11(1)：112-113.
[11]邢晓燕，张艳娜，李晓丽.醋氯芬酸钠和别嘌呤醇联合用药治疗痛风性关节炎的临床疗效及不良反应分析[J].智慧健康，2018，4(19)：125-126.
[12] Sarah Stewart，Nicola Dalbeth，Alain C Vandal，et al.Spatiotemporal gait parameters and plantar pressure distribution during barefoot walking in people with gout and asymptomatic hyperuricemia：comparison with healthy individuals with normal serum urate concentrations[J].Journal of Foot and Ankle Research，2016，9(1)：15., http://www.100md.com(刘南平)
[1]陶小军，金星，陶沙，等.不同剂量非布司他对痛风伴高尿酸血症的效果及对内皮素-1水平的影响[J].中国全科医学，2014，17(2)：170-172.
[2]陈翔，蔡吓明，陈国勇.非布司他治疗痛风伴高尿酸血症疗效观察[J].中外医学研究，2015，13(34)：34-36.
[3] Bhat V，Sankaran H，Narula G，et al.Banavali.Single fixed dose rasburicase for treatment of hyperuricemia in children with hematolymphoid malignancy and laboratory tumor lysis syndrome (tls)：a retrospective analysis.[J].Pediatric Hematology Oncology Journal，2018，3(3)：55-56.
[4] Jing-wei Wu，Ling Yin，Yu-qiang Liu，et al.Synthesis，biological evaluation and 3D-QSAR studies of 1，2，4-triazole-5-substituted carboxylic acid bioisosteres as uric acid transporter 1 (URAT1) inhibitors for the treatment of hyperuricemia associated with gout[J].Bioorganic & Medicinal Chemistry Letters，2018(4)：545.
[5]秦萍，劉蒙蒙，孟志云，等.非布司他治疗慢性肾衰竭非透析患者高尿酸血症的疗效观察[J].现代药物与临床，2016，31(2)：219-223.
[6] Om Prakash Sharma，Mahek V Shah，Dhaivat C Parikh，et al.
Formulation optimization of gastroretentive drug delivery system for allopurinol using experimental design[J].Expert Opinion on Drug Delivery，2015，12(4)：513-524.
[7] Helmy Sally A，El-Bedaiwy Heba M.Pharmacokinetics and comparative bioavailability of allopurinol formulations in healthy subjects[J].Clinical Pharmacology in Drug Development，2014，3(5)：353-357.
[8]陆玉鹏，李义凯，李益军，等.痛风定胶囊联合非布司他对高尿酸血症患者炎性因子的影响及其疗效[J].中国生化药物杂志，2016，36(1)：59-61.
[9] Keen H I，Davis W A，Drinkwater J J，et al.Ultrasonographic assessment of joint pathology in type 2 diabetes and hyperuricemia：The Fremantle Diabetes Study Phase Ⅱ[J].Journal of Diabetes and Its Complications，2018，32(4)：400-405.
[10]万志红.非布司他治疗痛风及高尿酸血症的疗效及不良反应观察[J].中国实用医药，2016，11(1)：112-113.
[11]邢晓燕，张艳娜，李晓丽.醋氯芬酸钠和别嘌呤醇联合用药治疗痛风性关节炎的临床疗效及不良反应分析[J].智慧健康，2018，4(19)：125-126.
[12] Sarah Stewart，Nicola Dalbeth，Alain C Vandal，et al.Spatiotemporal gait parameters and plantar pressure distribution during barefoot walking in people with gout and asymptomatic hyperuricemia：comparison with healthy individuals with normal serum urate concentrations[J].Journal of Foot and Ankle Research，2016，9(1)：15., http://www.100md.com(刘南平)